Orpyx Medical Technologies Inc has launched Orpyx SI Sensory Insoles with Remote Patient Monitoring for the prevention of diabetic foot ulcers (DFU) and neuropathy-related ulcers.
Designed to monitor pressure, temperature, and movement, the Orpyx SI Sensory Insole system provides wearers with real-time audiovisual alerts and allows them to immediately take action to resolve high-pressure areas that may lead to tissue breakdown.
Through a cloud-based dashboard, healthcare providers can monitor real-world data and identify trends to help make treatment decisions.
“It is our mission to eliminate preventable DFUs,” Dr Breanne Everett, Orpyx CEO and co-inventor, states in a media release from the Calgary, AB, Canada-based company.
“The development of the Orpyx SI Sensory Insole system was a true collaboration with our healthcare providers and patients,” adds JR Locey, VP of Commercial Operations.
“For the first time, we are able to offer sensory feedback through a simple user interface to provide real-time data. Previously, this type of accuracy was only available in a research setting, but now it can be used in the real world to help prevent DFUs.”
[Source(s): Orpyx Medical Technologies Inc, PR Newswire]
